TypeSafe AI
Developer infrastructure that turns unstructured inputs into typed decisions and probability scores for automated software workflows.
$870MSeries A
ParticipantD
DCVC
Activity from announced rounds
Activity in this selectionms-transverse-33c5f726
- Rounds participated in
- 11
- Confirmed lead rounds
- 1 8 roles undisclosed
- New companies
- 10 First participation on record · 1 follow-on
- Funding in participating rounds
- $1.7B 10 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
11 in this selectionTypeSafe AI
Developer infrastructure that turns unstructured inputs into typed decisions and probability scores for automated software workflows.
$40MSeed
LeadShennon Biotechnologies
Shennon Biotechnologies is developing precision T-cell engager immunotherapies for solid tumors.
$12MFunding
ParticipantCallosum
Software infrastructure allowing AI workloads to run across different chips and models
$100MSeed
Role not disclosedSabanto
Leader in autonomous retrofit technology for agriculture
UndisclosedSeries B
Role not disclosedAtom Computing
Develops large-scale neutral-atom quantum computers for fault-tolerant commercial and government applications
$100MSeries C
Role not disclosedQuantum Motion
Builds utility-scale quantum computers using industry-standard silicon transistors
$160MSeries C
Role not disclosedKanvas Biosciences
Develops microbiome-based live biotherapeutics for cancer patients who do not respond to immunotherapy
$48MSeries A
Role not disclosedHalter
Transforms cattle farming with GPS-enabled collars using software sensors and AI
$220MSeries E
Role not disclosedChariot Defense
Develops next-generation power distribution systems for modern warfare
$34MSeries A
Role not disclosedProxima
Develops AI-driven drug discovery for proximity therapeutics
$80MUndisclosed
Role not disclosed